Results 271 to 280 of about 2,450,636 (325)

HIV-1 infection regulates gene expression by altering alternative polyadenylation correlated with CPSF6 and CPSF5 redistribution. [PDF]

mBio
Luchsinger C, Dai AZ, Yalamanchili H, Balakrishnan A, Huang K-L, Bertelli C, Cui B, Lorenzo-Redondo R, Wagner EJ, Diaz-Griffero F.   +9 more
europepmc   +1 more source

Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity. [PDF]

J Virol
Jamieson PJ, Shen X, Abu-Shmais AA, Wasdin PT, Janowska K, Edwards RJ, Scapellato G, Bukenya M, Bass LE, Richardson SI, Manamela NP, Liu S, Barr M, Adams L, Paola Velez-Castro C, McCarthy C, Alexander CA, Gillespie RA, Mimms J, Suryadevara N, Sornberger TA, Zost SJ, Parks R, Flaherty S, Janke AK, Howard BN, Suresh YP, Ruprecht RM, Crowe JE, Carnahan RH, Bailey JR, Kanekiyo M, Lingwood D, Haynes BF, Moore PL, Bonami RH, Tomaras GD, Archarya P, Montefiori DC, Kalams SA, Lu S, Georgiev IS.   +41 more
europepmc   +1 more source

The role of acquired host immunity in periodontal diseases

Periodontology 2000, EarlyView.
Abstract The aim of this narrative review is to relate the contribution of European researchers to the complex topic of the host immune system in periodontal disease, focusing on acquired immunity. Other chapters in this volume will address the genetics and autoantibody responses and other forms of immunity to periodontal disease.
Denis F. Kinane, David F. Lappin, Shauna Culshaw   +2 more
wiley   +1 more source

Mycobacterium tuberculosis PE_PGRS62 Protein Inhibits Type I Interferon Responses to Promote HIV-2 Replication by Directly Interacting With Interferon Regulatory Factor 3. [PDF]

J Infect Dis
Pan C, Xu H, Huang M, He J, Li S, Tao X, Cao T, Zhang G.   +7 more
europepmc   +1 more source

Pan‐European Fragile Populations Cohort for COVID‐19: What Worked, What Didn't, and Lessons Learned

Transplant Infectious Disease, EarlyView.
ABSTRACT The COVID‐19 pandemic exposed the vulnerability of immunocompromised hosts and the scarcity of evidence guiding their management. Within the European Horizon 2020 ORCHESTRA project, a multinational consortium connected existing and new cohorts to harmonize data, laboratory methods, and clinical expertise across fragile populations. The fragile
Beatrice Tazza, Cecilia Bonazzetti, Natascia Caroccia, Michela Di Chiara, Lorenzo Maria Canziani, Anna Maria Azzini, Zaira R. Palacios Baena, Paula Olivares‐Navarro, Jesús Rodríguez‐Baño, Evelina Tacconelli, Pierluigi Viale, Maddalena Giannella   +11 more
wiley   +1 more source

Distinguishing active HIV-1 infection from vaccine-induced seropositivity in HIV vaccine trial participants. [PDF]

Sci Adv
Dighe K, Colak O, Moitra P, Alafeef M, Skrodzki D, Aditya T, Saha P, Gunaseelan N, Hural J, Pinto C, Pan D.   +10 more
europepmc   +1 more source

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions

Transplant Infectious Disease, EarlyView.
Risk mitigation strategies, including donors/recipients screening, DNAemia monitoring in recipients at risk, CNI‐to‐mTOR inhibitors switch, antivirals, and rituximab for KICS, may mitigate the impact of HHV‐8/KSHV infection in SOT. This review provides an update on KICS, identifies research gaps, and summarizes advances in screening and management ...
Alessandra Mularoni, Andrea Cona, Malgorzata Mikulska, Francesca Pecoraro, Carlotta Piazza, Elda De Vita, Giada Pietrosi, Matteo Bulati, Tiziana Lazzarotto, Mario Luppi   +9 more
wiley   +1 more source

Challenges in the Vaccination of HIV-Infected Individuals. [PDF]

Vaccines (Basel)
Sisteré-Oró M, Güerri-Fernandez R, Plana M, Bocharov G, Meyerhans A.   +4 more
europepmc   +1 more source

Systemic barriers to donation for African, Caribbean and Black communities: A qualitative key informant study

Transfusion Medicine, EarlyView.
Abstract Background and Objective For many blood collection agencies (BCAs), meeting the transfusion needs of people living with sickle cell disease, a genetic condition that causes sickling of red blood cells, is a priority but also a challenge because of a lack of diversity in the donor base.
Jennie Haw, Joyeuse Senga, Dzifa Dordunoo, Biba Tinga   +3 more
wiley   +1 more source

Toward CAR-B cells for HIV-1 therapy. [PDF]

Mol Ther Methods Clin Dev
Yin Y, Farzan M.
europepmc   +1 more source